June 15, 2021
Ten years ago, a seminal paper published by Cytel Founder Cyrus Mehta, introduced the Promising Zone Design to..
June 9, 2021
When selecting clinical trial designs, how many design options should a sponsor explore? Would a sponsor feel more..
June 2, 2021
For many decades the Pareto Frontier has been employed by actors in the private sector to evaluate and understand the..
May 14, 2021
When developing clinical strategy, applying familiar business principles to the specific requirements of clinical..
May 4, 2021
As healthcare systems across the world, continue to grapple with the pressures of COVID-19, Cytel advances yet another..
April 28, 2021
Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,..
April 23, 2021
The urgent need to discover and assess the efficacy and safety of COVID-19 vaccine candidates will affect the future..
January 26, 2021
Bayesian models offer a flexible way of incorporating historical controls in the analysis of trial data (whether single..
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..